Hydrofarm settlement: 300K preferred shares if milestones met
Conversion of the preferred shares into 300,000 common shares depends on the stockholder approval required by Nasdaq rules.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
Hydrofarm Holdings Group, Inc. agreed to a full, final and complete settlement of all claims related to the parties’ engagement and, subject to certain milestones, agreed to issue 300,000 shares of a newly designated non-voting, convertible preferred stock. The preferred shares will be convertible in the aggregate into 300,000 common shares upon stockholder approval of the conversion shares as required by Nasdaq rules.
The offer and issuance rely on the Securities Act’s Section 4(a)(2) exemption and Rule 506(b) of Regulation D. The recipient represented that it is an accredited investor acquiring the preferred shares and any conversion shares for its own account and investment purposes. The shares are subject to transfer restrictions under federal and state securities laws. Hydrofarm posted an investor presentation on October 7, 2026, and intends to use it from time to time in communications with investors, analysts and other market participants.
Insights
Analyzing...
8-K Event Classification
3 items: 3.02, 7.01, 9.01
3 items
Item 3.02
Unregistered Sales of Equity Securities
Securities
The company sold equity securities in a private placement or other unregistered transaction.
Item 7.01
Regulation FD Disclosure
Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Preferred shares: 300,000 shares
Common shares issuable upon conversion: 300,000 shares
2 metrics
Preferred shares
300,000 shares
Issuance is subject to certain milestones
Common shares issuable upon conversion
300,000 shares
Convertible in the aggregate upon required stockholder approval
Key Terms
non-voting, convertible series of preferred stock, Certificate of Designation, Section 4(a)(2), Rule 506(b), +1 more
5 terms
non-voting, convertible series of preferred stock financial
"newly designated non-voting, convertible series of preferred stock"
Certificate of Designation regulatory
"set forth in a Certificate of Designation"
A certificate of designation is a formal document that spells out the specific rights and rules attached to a particular class or series of stock, usually preferred shares. Think of it as a rulebook or menu that lists dividend terms, liquidation priority, conversion or redemption rights and any special voting protections; investors use it to judge how much income, control or downside protection those shares will provide compared with other securities.
Section 4(a)(2) regulatory
"exemption from registration provided by Section 4(a)(2)"
Section 4(a)(2) is a part of U.S. securities laws that allows companies to sell their stock directly to certain investors without registering the sale with regulators. This process is often used for private placements, making it easier and faster for companies to raise money from knowledgeable or institutional investors. It matters to investors because it provides an alternative way to buy shares, often with fewer disclosures and lower costs.
Rule 506(b) regulatory
"Rule 506(b) of Regulation D"
Rule 506(b) is a U.S. securities exemption that lets companies sell shares or debt privately without full public registration, provided sales are primarily to accredited investors, up to 35 non‑accredited but financially knowledgeable buyers, and there is no public advertising or solicitation. It matters to investors because offerings under 506(b) usually include less public disclosure than registered securities—like buying from a private seller rather than a retail store—so buyers must do more of their own fact‑checking and rely on their financial sophistication.
accredited investor regulatory
"an “accredited investor” as defined in Rule 501(a)"
An accredited investor is an individual or entity that meets certain financial criteria, such as having a high income or significant net worth, allowing them to invest in private or less regulated investment opportunities. This status matters because it grants access to investments that are often riskier or less available to the general public, reflecting a higher level of financial knowledge or resources.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): October 5, 2026
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) |
(Address of Principal Executive
Offices) (Zip Code)
Registrant’s telephone number, including area code: (707 ) 765-9990
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading symbol(s) | Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 3.02 Unregistered Sales of Equity Securities.
On October 5, 2026, Hydrofarm Holdings Group, Inc. (the "Company") entered into an agreement and mutual release (the “Agreement”) providing for the full, final and complete settlement of all claims by the parties related to their engagement. In connection with the Agreement, the Company agreed to, among other things and subject to certain milestones, issue 300,000 shares of a newly designated non-voting, convertible series of preferred stock of the Company (the “Preferred Shares”). The Preferred Shares will have the designations, powers, preferences, qualifications, limitations and restrictions to be set forth in a Certificate of Designation including that the Preferred Shares will be convertible in the aggregate into 300,000 shares of common stock of the Company (the “Common Stock” and such shares issuable upon conversion, the “Conversion Shares”) upon approval of issuance of the Conversion Shares by the Company’s stockholders as required by applicable rules of The Nasdaq Stock Market LLC.
The offer and issuance of the Preferred Shares is made in reliance upon the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506(b) of Regulation D promulgated thereunder. The recipient of the Preferred Shares represented to the Company that it is an “accredited investor” as defined in Rule 501(a) of Regulation D under the Securities Act and is acquiring the Preferred Shares and will acquire any Conversion Shares, for its own account and for investment purposes only. No general solicitation or advertising was used in connection with the offer and issuance of the Preferred Shares. The Preferred Shares are subject to restrictions on transfer under applicable federal and state securities laws.
Item 7.01 Regulation FD Disclosure.
On October 7, 2026, the Company posted a presentation (the "Presentation") to the "Investors" section of its website at https://www.hydrofarm.com/. The Company intends to use the Presentation, in whole or in part, from time to time in meetings and other communications with investors, analysts, and other market participants. A copy of the Presentation is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference.
The reference to our website is an inactive textual reference only and, except for the specific incorporated documents listed herein, the information contained in or accessible through our website does not constitute a part of this Current Report on Form 8-K and is not incorporated by reference herein.
The information furnished pursuant to this Item 7.01, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01 Financial Statements and Exhibits.
Exhibit No. | Description | ||
99.1 | Presentation dated October 7, 2026 | ||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Hydrofarm Holdings Group, Inc. |
|||
Date: October 9, 2026 | By: | /s/ William Toler |
|
Name: | William Toler |
||
Title: | Chief Executive Officer & Chairman of the Board of Directors |
||
(Principal Executive Officer) |
|||
Exhibit 99.1
